Denmark Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$1995
Buy Report View Sample

Published: November 22, 2022 Report Code: GDHC0072CHR-ST

Select Item

The Denmark pharmaceutical market size was $3.9 billion in 2020 and its medical devices market size was $1.9 billion in 2021. Both the markets foresee a CAGR of more than 3% during 2022-2027. In 2021, the government of Denmark revealed its new life sciences industrial strategy with many new projects across seven major industries. The strategy emphasized improving the environment for R&D and using health data, as well as securing a highly educated workforce and laying the framework for the country’s industry’s worldwide expansion, which aimed to benefit Denmark’s patients and economy.

The Denmark healthcare market research report is an essential source of information on the analysis of the healthcare, regulatory, and reimbursement landscape in Denmark. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory, and reimbursement landscape, and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets.

Denmark Pharmaceutical Market Overview

Denmark Pharmaceutical Market Overview

To gain more information on the Denmark pharmaceutical market forecast, download a free report sample

Denmark Medical Devices Market Overview

Denmark Medical Devices Market Overview

To gain more information on the Denmark medical devices market forecast, download a free report sample

Denmark Pharmaceuticals Market Segmentation by Import and Export Partners

The key import partners of Denmark pharmaceuticals market are Germany, Belgium, the Netherlands, Czech Republic, and Sweden. Germany accounts for the highest percentage of the import business. The key export partners of Denmark pharmaceuticals market are Germany, the US, Sweden, the Netherlands, and Finland. Germany also accounts for the highest percentage of the export business.

Denmark Pharmaceuticals Market Analysis by Import Partners

Denmark Pharmaceuticals Market Analysis by Import PartnersFor more import partner insights into the Denmark pharmaceuticals market, download a free report sample

Denmark Pharmaceuticals Market Analysis by Export Partners

Denmark Pharmaceuticals Market Analysis by Export PartnersFor more export partner insights into the Denmark pharmaceuticals market, download a free report sample

Denmark Pharmaceuticals Market Segments

The key segments in the Denmark pharmaceuticals market are generics, biologics, biosimilars, and over-the-counter (OTC) medicines.

Denmark Medical Devices Market Segments

The key segments in the Denmark medical devices market are hospital supplies, wound care management, cardiovascular devices, orthopedic devices, general surgery devices, and others. In 2021, hospital supplies had the highest share of Denmark medical devices market.

Denmark Medical Devices Market Analysis by Segments

Denmark Medical Devices Market Analysis by Segments

For more segment insights into the Denmark medical devices market, download a free report sample

Denmark Pharmaceuticals Market – Competitive Landscape

The leading players in the Denmark pharmaceuticals market are Pfizer, GlaxoSmithKline (GSK), Sanofi, Novo Nordisk, and LEO Pharma.

Denmark Pharmaceuticals Market Analysis by Players

Denmark Pharmaceuticals Market Analysis by Players

To know more about leading players in the Denmark pharmaceuticals market, download a free report sample

Denmark Medical Devices Market – Competitive Landscape

The major players in the medical devices market of Denmark are Abbott, Medtronic, Zimmer Biomet, Getinge, and Coloplast.

Denmark Medical Devices Market Analysis by Players

Denmark Medical Devices Market Analysis by PlayersTo know more about leading players in the Denmark medical devices market, download a free report sample

Denmark Pharmaceuticals Market Report Overview

Market Size (2020) $3.9 billion
CAGR (2022-2027)  >3%
Key Segments Generics, Biologics, Biosimilars, and Over-the-Counter (OTC) Medicines
Key Import Partners Germany, Belgium, Netherlands, Czech Republic, and Sweden
Key Export Partners The US, Germany, Sweden, Netherlands, and Finland
Leading Players Pfizer, GlaxoSmithKline (GSK), Sanofi, Novo Nordisk, and LEO Pharma

Denmark Medical Devices Market Report Overview

Market Size (2021) $1.9 billion
CAGR (2022-2027)  >3%
Key Segments Hospital Supplies, Wound Care Management, Cardiovascular Devices, Orthopedic Devices, General Surgery Devices, And Others
Leading Players Abbott, Medtronic, Zimmer Biomet, Getinge, and Coloplast

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Denmark, and includes:

  • An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers.
  • Profiles and SWOT analyses of the major players in the pharmaceutical market.
  • Profiles and SWOT analyses of the major players in the medical device market.
  • An insightful review of the COVID-19 epidemiology, COVID-19 impact and developments in the healthcare market, HealthTech landscape, reimbursement, and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies, and the approval processes for new drugs and medical devices.
  • Detailed analysis of the country’s healthcare policy highlights, demographics, healthcare infrastructure, and healthcare expenditure.
  • An overview of the opportunities for and challenges to growth in the Denmark healthcare market.

Reasons to Buy

This report will enhance your decision-making capability by allowing you to:

  • Develop business strategies by understanding the trends shaping and driving the Denmark healthcare market

  • Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the Denmark healthcare market in the future

  • Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance

  • Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership

Table of Contents

1. Table of Contents

1.1 List of Figures

1.2 List of Tables

2. Executive Summary

2.1 Executive Summary

2.2 Key Highlights: Facts About the Danish Healthcare Market

2.3 Key Highlights: Healthcare Startups in Denmark

2.4 Key Events: Danish Healthcare Industry, 2016–22

2.5 Key Events: Denmark Pharmaceutical Market

2.6 Key Events: M&As, VC & PE Deals, Global Pharmaceutical Market, 2021–22

2.7 Key Events: Top Completed Deals by Value, 2022

2.8 Country Profile, Denmark, 2022

3. Overview of Pharmaceutical Market

3.1 Pharmaceutical Market – Overview

3.2 Pharmaceutical Market – Exports

3.3 Pharmaceutical Market – Imports

3.4 Pharmaceutical Market – Supply Channels, Denmark

3.5 Pharmaceutical Market – Market Segments

3.6 Pharmaceutical Market – Market Segments, Generics, Denmark

3.7 Pharmaceutical Market – Market Segments, Biologics and Biosimilars, Denmark

3.8 Pharmaceutical Market – Market Segment, Over-the-Counter Medicines, Denmark

3.9 Major Therapeutic Areas, Denmark

3.10 COVID-19 Epidemiology, Denmark

3.11 COVID-19 Impact and Developments, Denmark

3.12 COVID-19 Impact and Developments in the Healthcare Market, Denmark

3.13 COVID-19 Clinical Trials Landscape, Denmark

3.14 Pharmaceutical Market – Major Players

4. Overview of Medical Devices Market

4.1 Medical Device Market – Overview

4.2 Medical Devices Market – Major Players

5. Pharmaceutical and Medical Devices Market – Drivers and Barriers

5.1 Drivers

5.2 Barriers

6. Deal Analysis

6.1 Deal Analysis: Pharmaceutical Market, Denmark, 2020–22

6.2 Deal Analysis: Medical Device Market, Denmark, 2020–22

7. HealthTech Landscape

7.1 HealthTech Landscape, Denmark

7.2 HealthTech Deals Landscape, Denmark

7.3 Key Healthtech Deals, Denmark

7.4 Adoption of Technology in Healthcare, Denmark

7.5 Digital Statistics, Denmark

7.6 Digital Health Regulations, Denmark

7.7 Healthtech Landscape: Benefits and Risks, Denmark

8. Market Access

8.1 Overview of Healthcare System, Denmark

8.2 Reimbursement Process, Denmark

8.3 Overview of Insurance Providers, Denmark

8.4 Healthcare Spending and Pharmaceutical Price Index, Denmark

8.5 Pricing Policies, Denmark

8.6 Regulatory Landscape, Denmark

8.6.1 Marketing Authorization for Pharmaceutical Products, Denmark

8.6.2 Marketing Authorization for Pharmaceutical Products, EU

8.6.3 Marketing Authorization for Pharmaceutical Products, Centralized Procedure, Denmark

8.6.4 Marketing Authorization for Pharmaceutical Products, Decentralized Procedure, Denmark

8.6.5 Marketing Authorization for Pharmaceutical Products, Mutual Recognition Procedure, Denmark

8.6.6 Marketing Authorization for Pharmaceutical Products, National Procedure, Denmark

8.6.7 Marketing Authorization for Pharmaceutical Products, Generic Medicines, Denmark

8.6.8 Marketing Authorization for Pharmaceutical Products, Biosimilars, Denmark

8.6.9 Marketing Authorization for Medical Devices, Denmark

8.6.10 Intellectual Property Rights, Patents, Denmark

8.6.11 Intellectual Property Rights, Trademarks, Denmark

8.6.12 Clinical Trial Regulation Process, Denmark

8.6.13 Pharmaceutical Clinical Trials Landscape, Denmark

8.6.14 Medical Devices Clinical Trials Landscape, Denmark

8.6.15 Exports and Imports Regulations, Denmark

8.6.16 Pharmacy License Regulations, Denmark

8.6.17 Online Pharmacy Regulations, Denmark

8.6.18 Pharmaceutical Advertising Regulations, Denmark

8.6.19 Labeling and Packaging Regulations, Denmark

9. Country Healthcare Landscape

9.1 Denmark Healthcare Policy Highlights

9.2 Healthcare Facilities, Denmark

9.3 Life Expectancy and Immunization Rate, Denmark

9.4 Environmental Health, Denmark

9.5 Healthcare Personnel, Denmark

9.6 Disease Burden, Denmark

9.7 Healthcare Expenditure, Denmark

9.8 Healthcare Spending Components and Pharmaceutical Spending, Denmark

10 Trade Associations, Denmark

11 Trade Fairs, Denmark

12 Opportunities and Challenges

13 Appendix

13.1 Research Methodology

13.1.1 Coverage

13.1.2 Secondary Research

13.1.3 Forecasts

13.2 Bibliography

13.3 About GlobalData

13.4 Contact Us

13.5 Disclaimer

Table

Table 1: Patent expiry of drugs, EU, 2022

Table 2: COVID-19 indicators (number), Denmark and Global, 2022

Table 3: COVID-19-related travel restrictions, Denmark, 2020–22

Table 4: Medical devices market, major segments ($M), Denmark, 2021

Table 5: Hospital supplies market, revenue ($M) and market share (%) of major companies, Denmark, 2021

Table 6: Wound care management market, revenue ($M) and market share (%) of major companies, Denmark, 2021

Table 7: Cardiovascular devices market, revenue ($M) and market share (%) of major companies, Denmark, 2021

Table 8: Orthopedic devices market, revenue ($M) and market share (%) of major companies, Denmark, 2021

Table 9: General surgery devices market, revenue ($M) and market share (%) of major companies, Denmark, 2021

Table 10: Net assessment and clock stop times, Denmark, 2022

Table 11: Market authorization fees, Denmark, 2022

Table 12: Registration fees for medical devices manufacturers, Denmark, 2022

Table 13: Patent fees, Denmark, 2022

Table 14: Trademark fees, Denmark, 2022

Table 15: Clinical trial fees, Denmark, 2022

Table 16: Trade fairs, Denmark, 2022

Figures

Figure 1: Pharmaceutical market, revenue (DKKB and $B), Denmark, 2015–21

Figure 2: Medical devices market, revenue ($B), Denmark, 2016–22

Figure 3: Healthcare start-ups in Denmark, 2022

Figure 4: Country profile, Denmark, 2022

Figure 5: Pharmaceutical market, revenue (DKKB and $B), Denmark, 2015–21

Figure 6: Pharmaceutical market, revenue forecast (DKKB and $B), Denmark, 2022–27

Figure 7: Danish growth strategy for life sciences, Denmark, 2018–23

Figure 8: Pharmaceutical exports ($B), Denmark, 2015–21

Figure 9: Top export partners, Denmark, 2021

Figure 10: Pharmaceutical imports ($B), Denmark, 2015–21

Figure 11: Top import partners, Denmark, 2021

Figure 12: Pharmaceutical supply channel, Denmark, 2022

Figure 13: Total sales of generic medicines in the primary health sector (DKKM and $M), Denmark, 2016–22

Figure 14: Generic drugs usage, third-party-payer market, (% share by value and volume), Denmark, 2016–22

Figure 15: Generic drugs usage, community pharmacy market, (% share by value and volume), Denmark, 2016–22

Figure 16: OTC medicines market, revenue ($M), Denmark, 2015–21

Figure 17: OTC market by sub-categories of drugs, revenue ($M), Denmark, 2021

Figure 18: Major therapeutic areas by pharmaceutical sales ($M), Denmark, 2021

Figure 19: Major therapeutic areas by DDD per 1000 inhabitants per day, Denmark, 2021

Figure 20: COVID-19 (number of cases), Denmark, 2020–22

Figure 21: COVID-19 (number of deaths), Denmark, 2020–22

Figure 22: Stringency index, COVID-19, Denmark, 2020–22

Figure 23: Containment and health index, COVID-19, Denmark, 2020–22

Figure 24: Top five COVID-19 markets by product categories (number of available marketed products), Denmark, 2020–22

Figure 25: Top five COVID-19 markets by equipment type (number of available marketed products), Denmark, 2020–22

Figure 26: Top five COVID-19 device classes (number of available marketed products), Denmark, 2020–22

Figure 27: Top five COVID-19 product manufacturers (number of available marketed products), Denmark, 2020–22

Figure 28: COVID-19 Vaccine doses administration, number of vaccine doses administered, Denmark, 2020-22

Figure 29: COVID-19 Vaccine booster doses administration, number of booster doses administered per 100 population, Denmark, 2021-22

Figure 30: COVID-19 clinical trial sponsors by trial count, Denmark, 2020–22

Figure 31: COVID-19 clinical trials count by phase, Denmark, 2020–22

Figure 32: COVID-19 clinical trials count by trial status, Denmark, 2020–22

Figure 33: Medical devices market, ($B), Denmark, 2016–21

Figure 34: Medical devices market, revenue forecast ($B), Denmark 2022–27

Figure 35: Medical devices market, major segments (%), Denmark, 2021

Figure 36: Hospital supplies market, revenue ($M), Denmark, 2017–27

Figure 37: Hospital supplies market, market share of major players (%), Denmark, 2021

Figure 38: Wound care management market, revenue ($M), Denmark, 2017–27

Figure 39: Wound care management market, market share of major players (%), Denmark, 2021

Figure 40: Cardiovascular devices market, revenue ($M), Denmark, 2017–27

Figure 41: Cardiovascular devices market, market share of major players (%), Denmark, 2021

Figure 42: Orthopedic devices market, revenue ($M), Denmark, 2017–27

Figure 43: Orthopedic devices market, market share of major players (%), Denmark, 2021

Figure 44: General surgery devices market, revenue ($M), Denmark, 2017–27

Figure 45: General surgery devices market, market share of major players (%), Denmark, 2021

Figure 46: Diagnostics market, revenue ($M), Denmark, 2016–21

Figure 47: Diagnostics market, revenue forecast ($M), Denmark, 2022–27

Figure 48: Medical devices market, revenue ($B) of major companies, Denmark, 2021

Figure 49: Deal value and deal count, pharmaceutical market, Denmark, 2020–22

Figure 50: Deal value and deal count subtypes, pharmaceutical market, Denmark, 2020–22

Figure 51: Deal value and deal count, quarterly, pharmaceutical market, Denmark, 2020–22

Figure 52: Top therapy areas by deal value ($M), pharmaceutical market, Denmark, 2020–22

Figure 53: VC deals quarterly, (by value and by number), pharmaceutical market, Denmark, 2020–22

Figure 54: Top therapy areas by deal count, pharmaceutical market, Denmark, 2020–22

Figure 55: M&A deals quarterly, (by value and by number), pharmaceutical market, Denmark, 2020–22

Figure 56: Deal value and deal count, medical devices market, Denmark, 2020–22

Figure 57: Deal value and deal count subtypes, medical devices market, Denmark, 2020–22

Figure 58: Deal value and deal count, quarterly, medical devices market, Denmark, 2020–22

Figure 59: Top equipment sectors by deal value ($M), medical devices market, Denmark, 2020–22

Figure 60: M&A deals, quarterly (by value and by number), medical devices market, Denmark, 2020–22

Figure 61: Top equipment sectors by deal count, medical devices market, Denmark, 2020–22

Figure 62: VC deals quarterly, (by value and by number), medical devices market, Denmark, 2020–22

Figure 63: Focus areas of Digital Health Strategy 2018–22, Denmark

Figure 64: Deal value ($M) and deal count (number of deals), Healthtech, Denmark, 2020–22

Figure 65: Deal value ($M) and deal count (number of deals) by deal sub-category, Healthtech, Denmark, 2020–22

Figure 66: Examples of digital health solutions by Danish Health Data Authority, Denmark, 2022

Figure 67: Digital health legislation principles, Denmark, 2018

Figure 68: Overview of Healthcare System, Denmark, 2022

Figure 69: Drug reimbursement (medicines reimbursement board process), Denmark, 2022

Figure 70: Private health insurance (% of total population), Denmark, 2012–22

Figure 71: Pharmaceutical Price Index, Denmark, 2012–22

Figure 72: OOP expenditure (% of total expenditure on health), Denmark, 2012–21

Figure 73: Danish Medicines Agency, Organization Chart, 2022

Figure 74: Drug authorization procedures, EU, 2022

Figure 75: The centralized procedure, Denmark, 2022

Figure 76: The decentralized procedure, Denmark, 2022

Figure 77: Mutual recognition procedure, Denmark, 2022

Figure 78: New drug approval process, Denmark, 2022

Figure 79: Medical device classification system, EU, 2022

Figure 80: Conformity assessment of Class I medical devices, EU,2022

Figure 81: Conformity assessment of Class IIa medical devices, EU,2022

Figure 82: Conformity assessment of Class IIb medical devices, EU,2022

Figure 83: Conformity assessment of Class III medical devices, EU,2022

Figure 84: Clinical trial approval process, Denmark, 2022

Figure 85: Pharmaceutical clinical trials count by trial status, Denmark, 2021–22

Figure 86: Top five pharmaceutical clinical trials sponsors by count, Denmark, 2021–22

Figure 87: Pharmaceutical clinical trials count by phase, Denmark, 2021–22

Figure 88: Pharmaceutical clinical trials count by therapy area, Denmark, 2021–22

Figure 89: Medical device clinical trials count by trial status, Denmark, 2021–22

Figure 90: Medical device clinical trials count by therapy area, Denmark, 2021–22

Figure 91: Medical device clinical trials count by market categories, Denmark, 2021–22

Figure 92: Top five medical device clinical trials sponsors by count, Denmark, 2021–22

Figure 93: Green EU logo, 2022

Figure 94: Number of public hospital beds (per 1,000 population), Denmark, 2015–22

Figure 95: Number of private hospital beds (per 1,000 population), Denmark, 2015–22

Figure 96: Number of hospital beds by function (per 1,000 population), Denmark, 2015–22

Figure 97: Number of CT scanners and PET scanners (per million population), Denmark, 2015–22

Figure 98: Immunization rate (%), Denmark, 2015–22

Figure 99: Life expectancy of males and females at birth (years), Denmark, 2015–22

Figure 100: CO2 emissions (million tons), Denmark, 2015–22

Figure 101: PM2.5 (µg per m3), Denmark, 2015–22

Figure 102: Practicing physicians (per 1,000 population), Denmark, 2015–22

Figure 103: Practicing dentists (per 1,000 population), Denmark, 2015–22

Figure 104: Practicing pharmacists (per 1,000 population), Denmark, 2015–22

Figure 105: Practicing nurses (per 1,000 population), Denmark, 2015–22

Figure 106: Major causes of mortality (per 100,000 population), Denmark, 2019

Figure 107: Major causes of male mortality (per 100,000 population), Denmark, 2019

Figure 108: Major causes of female mortality (per 100,000 population), Denmark, 2019

Figure 109: DALYs by major disease (per 100,000 population), Denmark, 2019

Figure 110: Healthcare expenditure as a percentage of GDP (%), Denmark, 2015–22

Figure 111: Health expenditure share (% of total health spending), Denmark, 2015–22

Figure 112: Pharmaceutical spending (% of health spending and $ per capita), Denmark, 2015–22

Figure 113: Healthcare expenditure components by function (% of total health expenditure), Denmark, 2021

Frequently asked questions

Denmark Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape standard reports
Currency USD
$1,995

Can be used by individual purchaser only

Most Popular
$2,992

Can be shared by unlimited users within one corporate location e.g. a regional office

$3,990

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Denmark Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more Pharmaceuticals reports
Pharmaceuticals
New
New Drug Approvals and Their Contract Manufacture - 2024 Edition
$4,995 | April 2024
Pharmaceuticals
New
Methicillin-Resistant Staphylococcus aureus (MRSA) Epidemiology Analysis and Forecast to 2033
$3,995 | April 2024
Pharmaceuticals
New
Antibody-Drug Conjugates (ADC) Overview, Industry Trends, Marketed and Pipeline Products,…
$6,995 | March 2024
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Denmark Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape in real time.

  • Access a live Denmark Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more